ViewRay today announced it is moving its headquarters to Denver to support the future growth of its cancer treatment systems.
The radiation therapy system maker in 2019 established an office in Denver that employed fewer than 10 people. It workforce in the area has since grown to over 50 employees as the company has expanded its international marketing, finance and legal teams.
With the expansion in Denver, ViewRay will add more jobs in product development, manufacturing and quality. It plans to add another building to its footprint in 2023 that will focus on development, manufacturing and physician training.
“ViewRay is excited that Colorado will be the international headquarters for this innovative cancer therapy. The state is a magnet for talented professionals and academics in our field and is fast becoming a center of the international bioscience industry,” President and CEO Scott Drake said in a news release.
ViewRay is developing its MRIdian radiation therapy treatment system that delivers radiation to targeted tumor sites. The company designed the system to give oncologists anatomical visualization through diagnostic-quality MR images and the ability to adapt a specific radiation therapy plan to targeted cancer for patients. ViewRay’s MRIdian system is currently installed in hospitals worldwide to treat solid tumors.
“We look forward to growing as a company, but more importantly, we are committed to conquering cancer by re-envisioning radiation therapy because lives depend on it. Patients deserve short-course non-invasive therapy with fewer side effects and better quality of life, whether they face complex or more common forms of cancer. ViewRay is committed to delivering that to every patient who requires treatment,” Drake said.
